GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,800 MG PER 180 ML (10 MG/ML) Trademark Information

Trademark by SUN PHARMACEUTICAL INDUSTRIES LIMITED

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and p...

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (010)
Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,800 MG PER 180 ML (10 MG/ML)
Status/Status Date:
REGISTERED
12/22/2020
Serial Number: 88125511
Filing Date: 9/20/2018
Registration Number: 6228560
Registration Date: 12/22/2020
Goods and Services: medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Mark Description: The mark consists of a green outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a green arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in green, with the words "1,800 mg per 180 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
Type Of Mark: TradeMark
Published For Opposition Date: 2/26/2019
Last Applicant/Owner:
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Mumbai, Maharashtra 400063
Mark Drawing Code: Drawing/Design + Words
Design Search:
Two rectangles (Geometric figures and solids - Rectangles) see more design...
Rectangles that are completely or partially shaded (Geometric figures and solids - Rectangles) see more design...
Curved line(s), band(s) or bar(s) (Geometric figures and solids - Lines, bands, bars, chevrons and angles) see more design...
Register Type: Principal
Disclaimer: ("GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,800 MG PER 180 ML (10 MG/ML)")
Correspondent:
SUN PHARMACEUTICAL INDUSTRIES, INC.
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON NJ 08540
Current Status:
REGISTERED
12/22/2020
Correspondent Search:
CRAIG KUCHII, ESQ. is a correspondent of GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,800 MG PER 180 ML (10 MG/ML) trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on